A matched cohort study of convalescent plasma therapy for COVID‐19

Introduction COVID‐19, caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is a public health crisis. Prior studies demonstrated successful use of convalescent plasma therapy for treatment of other viral illnesses. Our primary objective was to evaluate treatment efficacy of conva...

Full description

Bibliographic Details

Published in:	Journal of clinical apheresis Vol. 36; no. 4; pp. 523 - 532
Main Authors:	Sostin, Oleg V., Rajapakse, Pramuditha, Cruser, Brigid, Wakefield, Dorothy, Cruser, Daniel, Petrini, Joann
Format:	Journal Article
Language:	English
Published:	Hoboken, USA John Wiley & Sons, Inc 01-08-2021 Wiley Subscription Services, Inc
Subjects:	Cohort analysis convalescent plasma therapy COVID-19 fresh frozen plasma Length of stay Mortality Plasma Severe acute respiratory syndrome coronavirus 2 COVID-19 convalescent plasma therapy fresh frozen plasma
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!